Stem Cell Technologies
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
112
NCT04590118
Allogeneic Mesenchymal Stem Cells for the Survivors of Ischemic Stroke Trial (ASSIST)
Phase: Phase 1/2
Role: Lead Sponsor
Start: Apr 26, 2021
Completion: Aug 1, 2023
NCT06111846
Study of Human Bone Marrow Mesenchymal Stem Cells in APAP
Phase: Phase 2
Start: Dec 25, 2023
Completion: Aug 30, 2026
NCT07177677
A Study of Mesenchymal Stem Cell in the Treatment of Autism Spectrum Disorder
Phase: Phase 1
Start: Sep 30, 2025
Completion: Aug 30, 2028
Loading map...